Efficacy comparison of Conbercept and Ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy

Efficacy comparison of Conbercept and Ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy

AIM: To analyze the effects of two kinds of anti-vascular endothelial growth factor(VEGF)drugs, conbercept and ranibizumab, on proliferative diabetic retinopathy(PDR)patients as pre-treatment for pars plana vitrectomy(PPV).<p>METHODS: From June 2016 to December 2016, 62 patients(64 eyes)aged 4...

Full description

Bibliographic Details
Main Authors: Ni Yin, Shuai Zhao, Hong-Na Zhu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2017-07-01
Series:Guoji Yanke Zazhi
Subjects:
conbercept
ranibizumab
proliferative diabetic retinopathy
pars plana vitrectomy
Online Access:http://ies.ijo.cn/cn_publish/2017/7/201707026.pdf

Internet

http://ies.ijo.cn/cn_publish/2017/7/201707026.pdf

Similar Items